2f74
From Proteopedia
Line 1: | Line 1: | ||
- | [[Image:2f74. | + | {{Seed}} |
+ | [[Image:2f74.png|left|200px]] | ||
<!-- | <!-- | ||
Line 9: | Line 10: | ||
{{STRUCTURE_2f74| PDB=2f74 | SCENE= }} | {{STRUCTURE_2f74| PDB=2f74 | SCENE= }} | ||
- | + | ===Murine MHC class I H-2Db in complex with human b2-microglobulin and LCMV-derived immunodminant peptide gp33=== | |
- | + | <!-- | |
- | + | The line below this paragraph, {{ABSTRACT_PUBMED_16375919}}, adds the Publication Abstract to the page | |
+ | (as it appears on PubMed at http://www.pubmed.gov), where 16375919 is the PubMed ID number. | ||
+ | --> | ||
+ | {{ABSTRACT_PUBMED_16375919}} | ||
==Disease== | ==Disease== | ||
Line 23: | Line 27: | ||
==Reference== | ==Reference== | ||
Structural basis of the differential stability and receptor specificity of H-2Db in complex with murine versus human beta2-microglobulin., Achour A, Michaelsson J, Harris RA, Ljunggren HG, Karre K, Schneider G, Sandalova T, J Mol Biol. 2006 Feb 17;356(2):382-96. Epub 2005 Dec 7. PMID:[http://www.ncbi.nlm.nih.gov/pubmed/16375919 16375919] | Structural basis of the differential stability and receptor specificity of H-2Db in complex with murine versus human beta2-microglobulin., Achour A, Michaelsson J, Harris RA, Ljunggren HG, Karre K, Schneider G, Sandalova T, J Mol Biol. 2006 Feb 17;356(2):382-96. Epub 2005 Dec 7. PMID:[http://www.ncbi.nlm.nih.gov/pubmed/16375919 16375919] | ||
+ | |||
+ | A structural basis for LCMV immune evasion: subversion of H-2D(b) and H-2K(b) presentation of gp33 revealed by comparative crystal structure.Analyses., Achour A, Michaelsson J, Harris RA, Odeberg J, Grufman P, Sandberg JK, Levitsky V, Karre K, Sandalova T, Schneider G, Immunity. 2002 Dec;17(6):757-68. PMID:[http://www.ncbi.nlm.nih.gov/pubmed/12479822 12479822] | ||
+ | |||
+ | Determination of structural principles underlying three different modes of lymphocytic choriomeningitis virus escape from CTL recognition., Velloso LM, Michaelsson J, Ljunggren HG, Schneider G, Achour A, J Immunol. 2004 May 1;172(9):5504-11. PMID:[http://www.ncbi.nlm.nih.gov/pubmed/15100292 15100292] | ||
[[Category: Homo sapiens]] | [[Category: Homo sapiens]] | ||
[[Category: Mus musculus]] | [[Category: Mus musculus]] | ||
Line 37: | Line 45: | ||
[[Category: Murine mhc]] | [[Category: Murine mhc]] | ||
[[Category: Receptor binding]] | [[Category: Receptor binding]] | ||
- | ''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on | + | |
+ | ''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Tue Jul 29 15:25:24 2008'' |
Revision as of 12:25, 29 July 2008
Contents |
Murine MHC class I H-2Db in complex with human b2-microglobulin and LCMV-derived immunodminant peptide gp33
Template:ABSTRACT PUBMED 16375919
Disease
Known disease associated with this structure: Hypoproteinemia, hypercatabolic OMIM:[109700]
About this Structure
2F74 is a Protein complex structure of sequences from Homo sapiens and Mus musculus. Full crystallographic information is available from OCA.
Reference
Structural basis of the differential stability and receptor specificity of H-2Db in complex with murine versus human beta2-microglobulin., Achour A, Michaelsson J, Harris RA, Ljunggren HG, Karre K, Schneider G, Sandalova T, J Mol Biol. 2006 Feb 17;356(2):382-96. Epub 2005 Dec 7. PMID:16375919
A structural basis for LCMV immune evasion: subversion of H-2D(b) and H-2K(b) presentation of gp33 revealed by comparative crystal structure.Analyses., Achour A, Michaelsson J, Harris RA, Odeberg J, Grufman P, Sandberg JK, Levitsky V, Karre K, Sandalova T, Schneider G, Immunity. 2002 Dec;17(6):757-68. PMID:12479822
Determination of structural principles underlying three different modes of lymphocytic choriomeningitis virus escape from CTL recognition., Velloso LM, Michaelsson J, Ljunggren HG, Schneider G, Achour A, J Immunol. 2004 May 1;172(9):5504-11. PMID:15100292
Page seeded by OCA on Tue Jul 29 15:25:24 2008